PubMed

Is weight loss beneficial for reduction of morbidity and mortality? What is the controversy about?

Nilsson PM.

Diabetes Care. 2008 Feb;31 Suppl 2:S278-83. Review.PMID: 18227497 [PubMed - indexed for MEDLINE]Related articlesFree article

[Pharmacological therapy of obesity]

Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.

G Ital Cardiol (Rome). 2008 Apr;9(4 Suppl 1):83S-93S. Italian. PMID: 18773755 [PubMed - indexed for MEDLINE]Related articles

Diabetes and obesity: new data on mechanisms and intervention trials.

Nilsson PM.

Expert Rev Cardiovasc Ther. 2005 Mar;3(2):243-7. Review.PMID: 15853598 [PubMed - indexed for MEDLINE]Related articles

[Cardiometabolic effects of rimonabant in obese/overweight subjects with dyslipidaemia or type 2 diabetes]

Scheen AJ, Van Gaal LF.

Rev Med Liege. 2007 Feb;62(2):81-5. French. PMID: 17461296 [PubMed - indexed for MEDLINE]Related articles

Obesity and cardiovascular disease.

Pérez Pérez A, Ybarra Muñoz J, Blay Cortés V, de Pablos Velasco P.

Public Health Nutr. 2007 Oct;10(10A):1156-63. Review.PMID: 17903325 [PubMed - indexed for MEDLINE]Related articles

Treatment modalities of obesity: what fits whom?

Hainer V, Toplak H, Mitrakou A.

Diabetes Care. 2008 Feb;31 Suppl 2:S269-77. Review.PMID: 18227496 [PubMed - indexed for MEDLINE]Related articlesFree article

CB1 receptor blockade and its impact on cardiometabolic risk factors: overview of the RIO programme with rimonabant.

Scheen AJ.

J Neuroendocrinol. 2008 May;20 Suppl 1:139-46. Review.PMID: 18426513 [PubMed - indexed for MEDLINE]Related articles

Bariatric surgery and reduction in morbidity and mortality: experiences from the SOS study.

Sjöström L.

Int J Obes (Lond). 2008 Dec;32 Suppl 7:S93-7. Review.PMID: 19136998 [PubMed - indexed for MEDLINE]Related articles

The Look AHEAD study: a description of the lifestyle intervention and the evidence supporting it.

Look AHEAD Research Group, Wadden TA, West DS, Delahanty L, Jakicic J, Rejeski J, Williamson D, Berkowitz RI, Kelley DE, Tomchee C, Hill JO, Kumanyika S.

Obesity (Silver Spring). 2006 May;14(5):737-52. Review. Erratum in: Obesity (Silver Spring). 2007 May;15(5):1339. Wadden, Thomas A [added]; West, Delia Smith [added]; Delahanty, Linda [added]; Jakicic, John [added]; Rejeski, Jack [added]; Williamson, Don [added]; Berkowitz, Robert I [added]; Kelley, David E [added]; Tomchee, Christine [added]; Hill, James O [added]; Kumanyika, Shiriki [added]. PMID: 16855180 [PubMed - indexed for MEDLINE]Related articlesFree article

Emerging concepts in the medical and surgical treatment of obesity.

Aylwin S, Al-Zaman Y.

Front Horm Res. 2008;36:229-59. Review.PMID: 18230906 [PubMed - indexed for MEDLINE]Related articles

[The endocannabinoid system, overweight, and the CB1-endocannabinoid-receptor antagonist rimonabant]

Boekholdt SM, Jukema JW, Peters RJ.

Ned Tijdschr Geneeskd. 2007 Nov 24;151(47):2615-9. Review. Dutch. PMID: 18161262 [PubMed - indexed for MEDLINE]Related articles

Influences of weight loss on long-term diabetes outcomes.

Aucott LS.

Proc Nutr Soc. 2008 Feb;67(1):54-9. Review.PMID: 18234132 [PubMed - indexed for MEDLINE]Related articles

The Swedish Obese Subjects (SOS) study--rationale and results.

Torgerson JS, Sjöström L.

Int J Obes Relat Metab Disord. 2001 May;25 Suppl 1:S2-4.PMID: 11466577 [PubMed - indexed for MEDLINE]Related articlesFree article

Does a weight loss medicine make sense for obese type 2 diabetes? New information on endocannabinoid blockers.

McCall AL.

Curr Diab Rep. 2007 Oct;7(5):329-32. No abstract available. PMID: 18173964 [PubMed - indexed for MEDLINE]Related articles

The management of obesity in type 2 diabetes mellitus.

Valsamakis G, Chetty RK, Kumar S.

Curr Med Res Opin. 2002;18 Suppl 1:s75-81. Review.PMID: 12365821 [PubMed - indexed for MEDLINE]Related articles

Weight loss in obese diabetic and non-diabetic individuals and long-term diabetes outcomes--a systematic review.

Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J, Grant AM.

Diabetes Obes Metab. 2004 Mar;6(2):85-94. Review.PMID: 14746573 [PubMed - indexed for MEDLINE]Related articles

The comparative effects of bariatric surgery on weight and type 2 diabetes.

Levy P, Fried M, Santini F, Finer N.

Obes Surg. 2007 Sep;17(9):1248-56. Review.PMID: 18074502 [PubMed - indexed for MEDLINE]Related articles

What is the potential role of cannabinoid-1 receptor blockade in glucose and lipid management?

Jensen MD.

Am J Med. 2007 Sep;120(9 Suppl 1):S25-31; discussion S31-2. Review.PMID: 17720358 [PubMed - indexed for MEDLINE]Related articles

Drugs in the treatment of obesity: sibutramine, orlistat and rimonabant.

Rubio MA, Gargallo M, Isabel Millán A, Moreno B.

Public Health Nutr. 2007 Oct;10(10A):1200-5. Review.PMID: 17903331 [PubMed - indexed for MEDLINE]Related articles

Rimonabant in obese patients with type 2 diabetes.

Roberfroid D.

Lancet. 2007 Feb 17;369(9561):553; author reply 554-5. No abstract available. PMID: 17307092 [PubMed - indexed for MEDLINE]Related articles